Interpace Biosciences, Inc. (IDXG)
1.95
-0.05
(-2.50%)
USD |
OTCM |
May 08, 16:00
Interpace Biosciences EPS Diluted (Quarterly) : 0.8178 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodesix, Inc. | -0.8071 |
| FONAR Corp. | 0.3058 |
| Thermo Fisher Scientific, Inc. | 4.426 |
| Innovative MedTech, Inc. | 0.0562 |
| Meridian Holdings, Inc. (California) | -0.016 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.75M |
| Revenue (Quarterly) | 9.224M |
| Total Expenses (Quarterly) | -13.53M |
| Enterprise Value | 52.69M |
| Gross Profit Margin (Quarterly) | 65.52% |
| Earnings Yield | 39.25% |
| Operating Earnings Yield | 9.57% |
| Normalized Earnings Yield | 39.04 |